Generation and use in adoptive immunotherapy of stem cell-like memory T cells
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 8, 2020
Grant Date -
N/A
app pub date -
Sep 22, 2017
filing date -
Sep 23, 2016
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Provided herein are methods of generating antigen-specific T cells for therapeutic administration to a human patient having or suspected of having a pathogen or cancer, utilizing stem cell-like memory T cells (TSCM cells). Also disclosed are antigen-specific T cells generated by such methods, and methods of treating a human patient using such antigen-specific T cells.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully